CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

NPM1 mutation (relapsed/refractory AML)

Gene: NPM1 · Type: mutation

Indications: Acute myeloid leukemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
RevumenibAcute myeloid leukemiaINDICATED
FDA Label
Label